Novel Technologies for Targeted Oral Peptide Delivery

Therapeutic value of biologics have amplified significantly, and in the search for the best treatment regimen, the oral route has been extensively evaluated because of its non-invasive and safe nature.
To address the challenges originating due to the physicochemical properties of biologics and hurdles in the GI tract, several conventional and novel approaches are being used.
In this presentation, we will discuss the challenges to oral peptide delivery and approached used to address these challenges, with a focus on clinical level technologies.